Skip to content

Pacira reiterated as buy by Wainwright, target upped to $59

March 3, 2017

Pacira Pharmaceuticals Inc (PCRX) was Reiterated by H.C. Wainwright to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 59 from a previous price target of $48 . H.C. Wainwright advised their Clients and Investors in a research report released on Mar 2, 2017.

http://bit.ly/2mSJdPq

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: